Written question asked by Martyn Day (Scottish National Party) on Monday, 9 July 2018, in the House of Commons. It was due for an answer on Thursday, 12 July 2018 (named day). It was answered by Steve Brine (Conservative) on Thursday, 12 July 2018 on behalf of the Department of Health and Social Care.
Tuberculosis: Antimicrobial Resistance
- Question
-
To ask the Secretary of State for Health and Social Care, for what reason Tuberculosis was excluded from the scope of the £10 million Small Business Research Initiative competition on antimicrobial resistance in humans.
- Answer
-
The Small Business Research Initiative competition is funded by a Department of Health and Social Care non-Official Development Assistance budget. Research specifically on Tuberculosis (TB) pathogens was deprioritised for this competition as there are established global funds targeting the development of new treatments for TB.
The United Kingdom is contributing to a reduction in drug resistant TB by implementing the Collaborative TB Strategy for England, which parallels and integrates with the aims and actions of the UK Antimicrobial Resistance strategy.
Secondary information
- Type
- Written question
- Reference
- 162105
- Session
- 2017-19
- Subjects
- Tuberculosis Antimicrobial resistance Small Business Research Initiative
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-09-30 07:49:11 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/162105
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/162105
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/162105